reviewImmunological ReviewsNov 11, 2004Closed access

Interferons, interferon‐like cytokines, and their receptors

Rutgers, The State University of New Jersey · Johnson University · +2 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Recombinant interferon-alpha (IFN-alpha) was approved by regulatory agencies in many countries in 1986. As the first biotherapeutic approved, IFN-alpha paved the way for the development of many other cytokines and growth factors. Nevertheless, understanding the functions of the multitude of human IFNs and IFN-like cytokines has just touched the surface. This review summarizes the history of the purification of human IFNs and the key aspects of our current state of knowledge of human IFN genes, proteins, and receptors. All the known IFNs and IFN-like cytokines are described [IFN-alpha, IFN-beta, IFN-epsilon, IFN-kappa, IFN-omega, IFN-delta, IFN-tau, IFN-gamma, limitin, interleukin-28A (IL-28A), IL-28B, and…

Citation impact

1,753
total citations
FWCI
27.97
Percentile
100%
References
223
Citations per year

Authors

3

Topics & keywords

Keywords
  • Biology
  • Receptor
  • Immunology
  • Signal transduction
  • Interferon
  • Cytokine
  • Cell biology
  • Genetics
UN Sustainable Development Goals
  • Partnerships for the goals
No related works found for this paper.